Friday, 25 September 2026European Markets

ADC SIIC Stock Tumbles 23% As Market Underperforms

Loading stream...

(vianews) - investors responded negatively to adc siic (aldv.pa) performance on wednesday, sending its stock plummeting 23.98% to eur0.07 by 16:08 est despite cac 40's rise of 0.48% compared to eur8,144.43 during this session. while adc siic recently experienced an upward trend, its 52-week high of eur0.08 remains 14% above current trading levels.

about adc siic

alliance developpement capital siic (adc siic) is a publicly traded real estate investment company focused on owning and managing residential properties near paris, france. formerly known as ad capital sa, adc siic's head office can be found in saint-josse-ten-noode, belgium.

yearly analysis

technical analysis

equity analysis

negative roe ratios indicate that a company is failing to generate profits efficiently and use shareholder equity effectively, thus depriving shareholders of its returns and not effectively managing their resources. an investment decision maker might take this into consideration when making their decisions as it indicates potential financial difficulties or mismanagement of resources by management practices that need further investigation; they might compare current roes against historical averages or those of similar companies within the same industry for comparison purposes.

more news about adc siic (aldv.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com